Table 4.
Comparison of treatment results between the high and low-intensity groups.
| Variable | High-Intensity Group (n = 6) |
Low-Intensity Group (n = 14) |
p-Value |
|---|---|---|---|
| Mean follow-up duration (years) | 10.8 ± 5.4 | 8.7 ± 5.2 | 0.179 |
| Mean annual rate of eGFR decline (mL/min/1.73 m2/year) | −1.2 ± 0.8 | −1.4 ± 2.3 | 0.701 |
| Time-averaged proteinuria (g/day) | 1.18 ± 0.54 | 0.57 ± 0.45 | 0.022 |
| Time to complete or partial remission after treatment (month) | 4.4 ± 7.1 | 6.0 ± 7.4 | 0.579 |
| Time to first relapse after complete or partial remission (month) | 15.1 ± 18.8 | 22.1 ± 31.0 | 0.905 |
| Frequency of relapses during follow-up duration (episodes/year) | 0.72 ± 0.60 | 0.09 ± 0.22 | 0.022 |
Data are presented as the mean ± standard deviation. eGFR, estimated glomerular filtration rate.